AQR Capital Management
MXCT icon

AQR Capital Management’s MaxCyte MXCT Stock Holding History

AQR Capital Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$858K Buy
1,221,182
+1,127,208
+1,199% +$1.05M ﹤0.01% 2860
2025
Q4 		$146K Sell
93,974
-297,019
-76% -$474K ﹤0.01% 3422
2025
Q3 		$618K Buy
390,993
+143,300
+58% +$249K ﹤0.01% 2703
2025
Q2 		$540K Buy
247,693
+152,192
+159% +$369K ﹤0.01% 2581
2025
Q1 		$261K Buy
95,501
+66,323
+227% +$261K ﹤0.01% 2751
2024
Q4 		$121K Buy
29,178
+16,613
+132% +$62.8K ﹤0.01% 2744
2024
Q3 		$48.9K Sell
12,565
-924
-7% -$3.89K ﹤0.01% 2706
2024
Q2 		$52.9K Sell
13,489
-1,906
-12% -$8.2K ﹤0.01% 2537
2024
Q1 		$64.5K Sell
15,395
-13,919
-47% -$65.3K ﹤0.01% 2367
2023
Q4 		$138K Buy
29,314
+13,450
+85% +$52.4K ﹤0.01% 2257
2023
Q3 		$49.5K Buy
+15,864
New +$63.8K ﹤0.01% 2285

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

AQR Capital Management's MXCT Position: Q1 2026 in Review

AQR Capital Management increased its MaxCyte (MXCT) stake by 1,199% in Q1 2026, buying an estimated $1.05M and bringing the position to 1,221,182 shares worth $858K. The position accounts for ﹤0.01% of the portfolio, ranked #2860.

AQR Capital Management first reported a position in MXCT in Q3 2023 and has held it in 11 quarters since. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • AQR Capital Management held 1,221,182 shares of MaxCyte worth $858K as of Q1 2026.
  • AQR Capital Management bought 1,127,208 MaxCyte shares in Q1 2026, an estimated $1.05M.
  • MaxCyte made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2860 holding.
  • AQR Capital Management first reported a position in MaxCyte in Q3 2023 and has held it in 11 quarters since.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.